Generic drug association names interim chief
NEWS IN BRIEF — Posted July 5, 2010
The Generic Pharmaceutical Assn. will have an interim executive director, GPhA Vice President of Policy Bob Billings, until a new president and CEO can be named, the group announced on June 22.
GPhA President and CEO Kathleen Jaeger resigned effective June 30. However, Jaeger will advise the association through the end of 2010. Jaeger joined GPhA in 2002, shortly after three trade associations merged to form the organization.
"Despite David and Goliath comparisons, the GPhA team has tremendously enhanced the visibility and influence of the trade association, and we've been successful at getting a seat at the table in critical industry debates," Jaeger said in a statement. The association represents manufacturers and distributors of finished generic pharmaceuticals, bulk active chemicals, and other suppliers of goods and services to the generic drug industry.
Note: This item originally appeared at http://www.ama-assn.org/amednews/2010/07/05/gvbf0705.htm.